cancer from semaglutide Can Cause Cancer? Know the Potential GLP-1 Risks A growing body of research

Initial BMI is at or above the 95th percentile for age and sex (obesity) Limitations Not to be used with other semaglutide products or GLP-1 receptor agonists Not studied for use with other weight-loss products Not studied in patients with a history of pancreatitis This service is outpatient only

Epithalon, Melatonin and Circadian Research Changes in hormone measurements have been reported, but clinical sleep improvement has not been demonstrated

We manage the insurance aspect, prior authorizations, and continuous care coordination, empowering you to stay focused on your health aspirations

Sources Wajdlich, M., & Nowicki, M

K., Hogan, M